Last reviewed · How we verify
Mometasone furoate dry powder inhaler — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Mometasone furoate dry powder inhaler (Mometasone furoate dry powder inhaler) — Organon and Co.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Mometasone furoate dry powder inhaler TARGET | Mometasone furoate dry powder inhaler | Organon and Co | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Mometasone furoate dry powder inhaler CI watch — RSS
- Mometasone furoate dry powder inhaler CI watch — Atom
- Mometasone furoate dry powder inhaler CI watch — JSON
- Mometasone furoate dry powder inhaler alone — RSS
Cite this brief
Drug Landscape (2026). Mometasone furoate dry powder inhaler — Competitive Intelligence Brief. https://druglandscape.com/ci/mometasone-furoate-dry-powder-inhaler. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab